Literature DB >> 24101467

Menin promotes hepatocellular carcinogenesis and epigenetically up-regulates Yap1 transcription.

Bin Xu1, Shan-Hua Li, Rong Zheng, Shu-Bin Gao, Li-Hong Ding, Zhen-Yu Yin, Xiao Lin, Zi-Jie Feng, Sheng Zhang, Xiao-Min Wang, Guang-Hui Jin.   

Abstract

Menin is a scaffold protein encoded by the multiple endocrine neoplasia type 1 (MEN1) gene in humans, and it interacts with a variety of transcriptional proteins to control active or repressive cellular processes. Here, we show that heterozygous ablation of Men1 in female mice reduces chemical carcinogen-induced liver carcinogenesis and represses the activation of the inflammation pathway. Using ChIP-on-chip screens and ChIP assays, we find that menin occupancy frequently coincides with H3K4me3 at the promoter of many liver cancer-related genes, such as Yes-associated protein (Yap1). Increased menin and Yap1 expression in human hepatocellular carcinoma specimens was associated with poor prognosis. Our findings reveal that menin plays an important epigenetic role in promoting liver tumorigenesis, and support the notion that H3K4me3, which is regulated by the menin-mixed-lineage leukemia complex, is a potential therapeutic target in hepatocellular carcinoma.

Entities:  

Keywords:  H3K4 methylation; interleukin 6

Mesh:

Substances:

Year:  2013        PMID: 24101467      PMCID: PMC3808599          DOI: 10.1073/pnas.1312022110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.

Authors:  J S Crabtree; P C Scacheri; J M Ward; L Garrett-Beal; M R Emmert-Buck; K A Edgemon; D Lorang; S K Libutti; S C Chandrasekharappa; S J Marx; A M Spiegel; F S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

2.  Positional cloning of the gene for multiple endocrine neoplasia-type 1.

Authors:  S C Chandrasekharappa; S C Guru; P Manickam; S E Olufemi; F S Collins; M R Emmert-Buck; L V Debelenko; Z Zhuang; I A Lubensky; L A Liotta; J S Crabtree; Y Wang; B A Roe; J Weisemann; M S Boguski; S K Agarwal; M B Kester; Y S Kim; C Heppner; Q Dong; A M Spiegel; A L Burns; S J Marx
Journal:  Science       Date:  1997-04-18       Impact factor: 47.728

3.  Upregulation of the tumor suppressor gene menin in hepatocellular carcinomas and its significance in fibrogenesis.

Authors:  Pierre J Zindy; Annie L'Helgoualc'h; Dominique Bonnier; Antony Le Béchec; Katia Bourd-Boitin; Chang Xian Zhang; Orlando Musso; Denise Glaise; Marie Bérangère Troadec; Olivier Loréal; Bruno Turlin; Jean Léger; Bruno Clément; Nathalie Théret
Journal:  Hepatology       Date:  2006-11       Impact factor: 17.425

4.  IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.

Authors:  Shin Maeda; Hideaki Kamata; Jun-Li Luo; Hyam Leffert; Michael Karin
Journal:  Cell       Date:  2005-07-01       Impact factor: 41.582

5.  The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.

Authors:  Akihiko Yokoyama; Tim C P Somervaille; Kevin S Smith; Orit Rozenblatt-Rosen; Matthew Meyerson; Michael L Cleary
Journal:  Cell       Date:  2005-10-21       Impact factor: 41.582

6.  Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription.

Authors:  S K Agarwal; S C Guru; C Heppner; M R Erdos; R M Collins; S Y Park; S Saggar; S C Chandrasekharappa; F S Collins; A M Spiegel; S J Marx; A L Burns
Journal:  Cell       Date:  1999-01-08       Impact factor: 41.582

7.  Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus.

Authors:  Christina M Hughes; Orit Rozenblatt-Rosen; Thomas A Milne; Terry D Copeland; Stuart S Levine; Jeffrey C Lee; D Neil Hayes; Kalai Selvi Shanmugam; Arindam Bhattacharjee; Christine A Biondi; Graham F Kay; Nicholas K Hayward; Jay L Hess; Matthew Meyerson
Journal:  Mol Cell       Date:  2004-02-27       Impact factor: 17.970

8.  HGF-MET signals via the MLL-ETS2 complex in hepatocellular carcinoma.

Authors:  Shugaku Takeda; Han Liu; Satoru Sasagawa; Yiyu Dong; Paul A Trainor; Emily H Cheng; James J Hsieh
Journal:  J Clin Invest       Date:  2013-06-24       Impact factor: 14.808

Review 9.  Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ.

Authors:  John P Iredale
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

10.  Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach.

Authors:  Lars Zender; Mona S Spector; Wen Xue; Peer Flemming; Carlos Cordon-Cardo; John Silke; Sheung-Tat Fan; John M Luk; Michael Wigler; Gregory J Hannon; David Mu; Robert Lucito; Scott Powers; Scott W Lowe
Journal:  Cell       Date:  2006-06-30       Impact factor: 41.582

View more
  33 in total

1.  miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma Proliferation.

Authors:  Laurent Ehrlich; Chad Hall; Julie Venter; David Dostal; Francesca Bernuzzi; Pietro Invernizzi; Fanyin Meng; Jerome P Trzeciakowski; Tianhao Zhou; Holly Standeford; Gianfranco Alpini; Terry C Lairmore; Shannon Glaser
Journal:  Am J Pathol       Date:  2017-01-11       Impact factor: 4.307

2.  Complexity of Blocking Bivalent Protein-Protein Interactions: Development of a Highly Potent Inhibitor of the Menin-Mixed-Lineage Leukemia Interaction.

Authors:  Dmitry Borkin; Szymon Klossowski; Jonathan Pollock; Hongzhi Miao; Brian M Linhares; Katarzyna Kempinska; Zhuang Jin; Trupta Purohit; Bo Wen; Miao He; Duxin Sun; Tomasz Cierpicki; Jolanta Grembecka
Journal:  J Med Chem       Date:  2018-05-23       Impact factor: 7.446

3.  Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivo.

Authors:  Dmitry Borkin; Shihan He; Hongzhi Miao; Katarzyna Kempinska; Jonathan Pollock; Jennifer Chase; Trupta Purohit; Bhavna Malik; Ting Zhao; Jingya Wang; Bo Wen; Hongliang Zong; Morgan Jones; Gwenn Danet-Desnoyers; Monica L Guzman; Moshe Talpaz; Dale L Bixby; Duxin Sun; Jay L Hess; Andrew G Muntean; Ivan Maillard; Tomasz Cierpicki; Jolanta Grembecka
Journal:  Cancer Cell       Date:  2015-03-26       Impact factor: 31.743

Review 4.  Challenges and opportunities in targeting the menin-MLL interaction.

Authors:  Tomasz Cierpicki; Jolanta Grembecka
Journal:  Future Med Chem       Date:  2014-03       Impact factor: 3.808

5.  MicroRNA-15b/16 Attenuates Vascular Neointima Formation by Promoting the Contractile Phenotype of Vascular Smooth Muscle Through Targeting YAP.

Authors:  Fei Xu; Abu Shufian Ishtiaq Ahmed; Xiuhua Kang; Guoqing Hu; Fang Liu; Wei Zhang; Jiliang Zhou
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-08-20       Impact factor: 8.311

6.  Pharmacologic Inhibition of the Menin-MLL Interaction Leads to Transcriptional Repression of PEG10 and Blocks Hepatocellular Carcinoma.

Authors:  Katarzyna Kempinska; Bhavna Malik; Dmitry Borkin; Szymon Klossowski; Shirish Shukla; Hongzhi Miao; Jingya Wang; Tomasz Cierpicki; Jolanta Grembecka
Journal:  Mol Cancer Ther       Date:  2017-11-15       Impact factor: 6.261

7.  Menin and Daxx Interact to Suppress Neuroendocrine Tumors through Epigenetic Control of the Membrane Metallo-Endopeptidase.

Authors:  Zijie Feng; Lei Wang; Yanmei Sun; Zongzhe Jiang; John Domsic; Chiying An; Bowen Xing; Jingjing Tian; Xiuheng Liu; David C Metz; Xiaolu Yang; Ronen Marmorstein; Xiaosong Ma; Xianxin Hua
Journal:  Cancer Res       Date:  2016-11-21       Impact factor: 12.701

8.  Modulation by miR-29b of intestinal epithelium homoeostasis through the repression of menin translation.

Authors:  Miao Ouyang; Weijie Su; Lan Xiao; Jaladanki N Rao; Liping Jiang; Yanwu Li; Douglas J Turner; Myriam Gorospe; Jian-Ying Wang
Journal:  Biochem J       Date:  2015-01-15       Impact factor: 3.857

9.  MiR-506 suppresses proliferation of hepatoma cells through targeting YAP mRNA 3'UTR.

Authors:  Yue Wang; Ming Cui; Bao-di Sun; Fa-bao Liu; Xiao-dong Zhang; Li-hong Ye
Journal:  Acta Pharmacol Sin       Date:  2014-08-04       Impact factor: 6.150

10.  MicroRNA-142-3p, a novel target of tumor suppressor menin, inhibits osteosarcoma cell proliferation by down-regulation of FASN.

Authors:  Yao-Qi Yang; Jin Qi; Jian-Qiang Xu; Ping Hao
Journal:  Tumour Biol       Date:  2014-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.